Drug profile · INN
tremelimumab
IMJUDO
- Patents linked
- 0
- News articles
- 0
Quick answer
tremelimumab (IMJUDO) is an FDA-listed pharmaceutical active ingredient. Associated with AstraZeneca.
Key facts
Frequently asked questions
What is tremelimumab?
tremelimumab (IMJUDO) is an FDA-listed pharmaceutical active ingredient. Associated with AstraZeneca.
What is the brand name for tremelimumab?
IMJUDO is a marketed brand name for tremelimumab. Check FDA Drugs@FDA for the current US label holder and prescribing information.